MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$1,131M
(-10.94%↓ Y/Y)
Non Us
$397M
(5.31%↑ Y/Y)
US
$465M
(35.57%↑ Y/Y)
Non Us
$411M
(31.31%↑ Y/Y)
US
$461M
(-35.97%↓ Y/Y)
Non Us
$266M
(-29.82%↓ Y/Y)
US
$431M
(34.69%↑ Y/Y)
Non Us
$131M
(7.38%↑ Y/Y)
US
$424M
(16.16%↑ Y/Y)
Non Us
$66M
(312.50%↑ Y/Y)
US
$352M
(2.62%↑ Y/Y)
Non Us
$79M
(-15.96%↓ Y/Y)
US
$221M
(-19.05%↓ Y/Y)
Non Us
$194M
(100.00%↑ Y/Y)
US
$283M
(40.80%↑ Y/Y)
Non Us
$129M
(15.18%↑ Y/Y)
US
$228M
(-36.67%↓ Y/Y)
Non Us
$183M
(-11.17%↓ Y/Y)
Revenue From Contract
With Customer...
$343M
(20.35%↑ Y/Y)
US
$218M
(0.93%↑ Y/Y)
Non Us
$112M
(3.70%↑ Y/Y)
US
$314M
(-37.70%↓ Y/Y)
Non Us
$6M
(0.00%↑ Y/Y)
Non Us
$234M
(-6.02%↓ Y/Y)
US
$77M
(-15.38%↓ Y/Y)
Non Us
$151M
(14.39%↑ Y/Y)
US
$136M
(0.74%↑ Y/Y)
US
$246M
(-95.66%↓ Y/Y)
Non Us
$16M
(-99.28%↓ Y/Y)
US
$188M
(-96.68%↓ Y/Y)
Non Us
$70M
(-96.83%↓ Y/Y)
Revenue From Contract
With Customer...
$255M
(8.05%↑ Y/Y)
Other Products
$1,528M
(-7.23%↓ Y/Y)
Repathaevolocumab
$876M
(33.54%↑ Y/Y)
Prolia
$727M
(-33.85%↓ Y/Y)
EVENITY
$562M
(27.15%↑ Y/Y)
TEPEZZA
$490M
(28.61%↑ Y/Y)
Otezla
$431M
(-1.37%↓ Y/Y)
BLINCYTO
$415M
(12.16%↑ Y/Y)
Nplate
$412M
(31.63%↑ Y/Y)
Xgeva
$411M
(-27.39%↓ Y/Y)
TEZSPIRE
$343M
(20.35%↑ Y/Y)
Kyprolis
$330M
(1.85%↑ Y/Y)
Enbrel
$320M
(-37.25%↓ Y/Y)
Aranesp
$311M
(-8.53%↓ Y/Y)
Vectibix
$287M
(7.49%↑ Y/Y)
UPLIZNA
$262M
IMDELLTRAIMDYLLTRA
$258M
KRYSTEXXA
$255M
(8.05%↑ Y/Y)
Product
$8,218M
(4.38%↑ Y/Y)
Product And Service
Other
$400M
(44.93%↑ Y/Y)
Total revenues
$8,618M
(5.76%↑ Y/Y)
Operating income
$2,666M
(126.32%↑ Y/Y)
Other income, net
$75M
(-95.06%↓ Y/Y)
Total operating
expenses
$5,952M
(-14.62%↓ Y/Y)
Other
-$113M
(-113.61%↓ Y/Y)
Income before income
taxes
$2,084M
(5.63%↑ Y/Y)
Interest expense, net
$657M
(-9.13%↓ Y/Y)
Cost of sales
$2,744M
(-7.55%↓ Y/Y)
Research and development
$1,719M
(15.68%↑ Y/Y)
Selling, general and
administrative
$1,602M
(-5.04%↓ Y/Y)
Net income
$1,819M
(5.14%↑ Y/Y)
Provision for income taxes
$265M
(9.05%↑ Y/Y)
Back
Back
Income Statement
amgen-blue-svg
AMGEN INC (AMGN)
amgen-blue-svg
AMGEN INC (AMGN)
source: myfinsight.com